This special episode is produced by Servier on French media outlet Le Parisien’s CODE SOURCE, a news podcast. You’ll get a better understanding of brain tumors, as well as an update on the progress of research in this field, particularly with the emergence of targeted therapies.
This episode features Maya, a patient facing brain cancer. Claude Bertrand, Executive Vice President of R&D at Servier and Dr. Delphine Larrieux, MD, Neuro-Oncologist, at the Claudius Regaud Cancer Center and Toulouse University Cancer Institute – Oncopole, are also interviewed.
“Our governance model through a Foundation allows us to focus fully on patients and their needs, and to take an interest in rare diseases, particularly in oncology. This is how we are able to invest in the long term, with a vision of medicine that truly transforms patients’ lives.”
Claude Bertrand, Executive Vice President of Research & Development, Servier
Glioma is the most common primary brain tumor in adults. While brain cancers are difficult to treat, detecting and removing the tumor as early as possible is crucial to optimizing prognosis.